REFERENCES
- Okuno K., Shigeoka H., Lee Y. S., et al. Adjuvant hepatic arterial IL-2 and MMC, 5-FU after curative resection of colorectal cancer liver metastases. Hepatogastroenterol 1996; 43: 688–91
- Rougier P., Laplanche A., Huguier M., et al. Hepatic arterial infusion of floxuridine in patients with liver metastases from colorectal carcinoma: long-term results of a prospective randomized trial. J Clin Oncol 1992; 10: 1112–8
- Wallace S., Chuang V. P., Samuels M., Johnson D. Transcatheter intraarterial infusion of chemotherapy im advanced bladder cancer. Cancer 1982; 49: 640–5
- Nagata Y., Araki N., Kimura H., et al. Neoadjuvant chemotherapy by transcatheter arterial infusion method for uterine cervical cancer. J Vasc Intervent Radiol 2000; 11: 313–19
- Harmantas A., Rotstein L. E., Langer B. Regional versus systemic chemotherapy in the treatment of colorectal carcinoma metastatic to the liver: Is there a survival difference? Meta-analysis of the published literature. Cancer 1996; 78: 1639–45
- Salts B. S., Cox J. V., Blanke C., et al. Irrinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. N Engl J Med 2000; 355: 1041–7
- Wanebo H. J., Koness R. J., Vezeridis M. P., Cohen S. I., Wrobleski D. E. Pelvic resection of recurrent rectal cancer. Ann Surg 1994; 220: 586–97
- Avizonis V. N., Sause W. T., Notes R. D. Morbidity and mortality associated with intraoperative radiotherapy. J Surg Oncol 1989; 41: 240–5
- Hurwitz H., Fehrenbacker L., Novotny W., et al. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med 2004; 350: 2335–42
- Van Custem E., Twelves C., Cassidy J., et al. Oral capecitabine compared with intravenous fluorouracil plus leucovorin in patients with metastatic colorectal cancer: results of a large phase III study. J Clin Oncol 2001; 19: 4097–106
- Goldberg R. M., Sargent D. J., Morton R. F., et al. A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer. J Clin Oncol 2004; 22: 23–30